American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan

Handelsman, Yehuda, Mechanick, Jeffrey I., Blonde, Lawrence, Grunberger, George, Bloomgarden, Zachary T., Bray, George A., Dagogo-Jack, Samuel, Davidson, Jaime A. +18 more·2011·Endocrine Practice
DOI 10.4158/ep.17.s2.1

Cited by (498)

Items 201–300 of 498

  1. Improving postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: R eview of current strategies
    Guillermo E. Umpierrez, Timothy Silleck Bailey, Danielle Carcia, Charles F. Shaefer, Jay H. Shubrook, NEIL SKOLNIK · 2017 · Journal of Diabetes
  2. Targeting erythropoietin protects against proteinuria in type 2 diabetic patients and in zebrafish
    J. She, Z. Yuan, Yuehua Wu, Junfang Chen, J. Kroll · 2017 · Molecular Metabolism
  3. Metabolic Effects of Basal or Premixed Insulin Treatment in 5077 Insulin-Naïve Type 2 Diabetes Patients: Registry-Based Observational Study in Clinical Practice
    Björn Eliasson, Nils Ekström, Sara Bruce Wirta, Anders Odén, MirNabi Pirouzi Fard, Ann‐Marie Svensson · 2014 · Diabetes Therapy
  4. Insulin plus incretin agent combination therapy in type 2 diabetes: a systematic review
    Ronald Goldenberg · 2013 · Current Medical Research and Opinion
  5. Exercising With Peripheral or Autonomic Neuropathy: What Health Care Providers and Diabetic Patients Need to Know
    Sheri R. Colberg, Aaron I. Vinik · 2014 · The Physician and Sportsmedicine
  6. Addition of exenatide twice daily to basal insulin for the treatment of type 2 diabetes: clinical studies and practical approaches to therapy
    Garry S. Tobin, Melissa K. Cavaghan, Byron J. Hoogwerf, Janet B. McGill · 2012 · International Journal of Clinical Practice
  7. Incretin therapy and its effect on body weight in patients with diabetes
    Marcus Lind · 2012 · Primary care diabetes
  8. The role of the nurse practitioner in the diagnosis and early management of type 2 diabetes
    Carolyn Robertson · 2012 · Journal of the American Academy of Nurse Practitioners
  9. Linagliptin: The Newest Dipeptidyl Peptidase-4 Inhibitor for Type 2 Diabetes Mellitus
    R. Aletti, A. Cheng-Lai · 2012 · Cardiology in Review
  10. Do patients with diabetes use the insulin pen properly?
    Betül Tosun, Fatma İlknur Çınar, Zeliha Topcu, Burcu Masatoglu, Nurten Özen, Gülcan Bağçıvan, Özge Kılıç, Canan Demirci, Ayten Altunbas, Alper Sönmez · 2019 · African Health Sciences
  11. Evaluation of Polyphenol and Flavonoid Profiles and the Antioxidant Effect of Carduus Acanthoides Hydroalcoholic Extract Compared with Vaccinium Myrtillus in an Animal Model of Diabetes Mellitus
    R. Văruţ, C. Gîrd, L. Rotaru, M. C. Varut, C. Pisoschi · 2018 · Pharmaceutical Chemistry Journal
  12. Lowering low-density lipoprotein cholesterol levels in patients with type 2 diabetes mellitus
    H. Bays · 2014 · International Journal of General Medicine
  13. Achieving glycaemic targets with basal insulin in T2DM by individualizing treatment
    Vivian Andrew Fonseca, Michelle Haggar · 2014 · Nature Reviews Endocrinology
  14. Clinically relevant reductions in HbA 1c without hypoglycaemia: results across four studies of saxagliptin
    Chetan S. Karyekar, Robert C. Frederich, Shivakumar Ravichandran · 2013 · International Journal of Clinical Practice
  15. Insulin Pumps in Pregnancy: Using Technology to Achieve Normoglycemia in Women with Diabetes
    KRISTIN N. CASTORINO, Rashid Paband, Howard Zisser, Lois Jovanovič · 2011 · Current Diabetes Reports
  16. Behavioral Analysis of Chinese Adult Patients with Type 1 Diabetes on Self-monitoring of Blood Glucose
    Zhao-Yi Qin, Jin-Hua Yan, Dai-Zhi Yang, Hong-Rong Deng, B. Yao, Jian-Ping Weng · 2017 · Chinese Medical Journal
  17. Effectiveness and safety of glimepiride and iDPP4, associated with metformin in second line pharmacotherapy of type 2 diabetes mellitus: systematic review and meta‐analysis
    J. Amate, T. López-Cuadrado, Nuria Almendro, C. Bouza, Z. Saz-Parkinson, R. Rivas-Ruíz, J. González-Canudas · 2015 · International journal of clinical practice
  18. Association between post-dinner dietary intakes and nocturnal hypoglycemic risk in adult patients with type 1 diabetes.
    K. Desjardins, A. Brazeau, I. Strychar, C. Leroux, V. Gingras, R. Rabasa-Lhoret · 2014 · Diabetes Research and Clinical Practice
  19. Diabetes Pharmacotherapy in 2012: Considerations in Medication Selection
    Susan A. Cornell, Vincent Dorsey · 2012 · Postgraduate Medicine
  20. Actualización en el diagnóstico, tratamiento y prevención de la neuropatía diabética periférica
    M. B. Velasco, D. Rodríguez, A. Rodriguez-Montalban, S. V. Jiménez, I. Fernández de Valderrama Martínez · 2017 · Angiología
  21. The Rationale for Continuous Glucose Monitoring-based Diabetes Treatment Decisions and Non-adjunctive Continuous Glucose Monitoring Use
    David A. Price, Tomas C. Walker · 2016 · touchREVIEWS in Endocrinology
  22. Effects of glycemic control upon serum lipids and lipid transfers to HDL in patients with type 2 diabetes mellitus: novel findings in unesterified cholesterol status.
    O. G. Laverdy, W. Hueb, M. C. Sprandel, R. Kalil-Filho, R. Maranhão · 2015 · Experimental and clinical endocrinology & diabetes
  23. Acromegaly: Role of Surgery in the Therapeutic Armamentarium
    G. Guinto, Miguel Abdo, E. Zepeda, N. Aréchiga, M. Mercado · 2012 · International Journal of Endocrinology
  24. The Two Skill Sets of Self-Monitoring of Blood Glucose Education: The Operational and the Interpretive
    Austin, Mary M. · 2013 · Diabetes Spectrum
  25. Evolution of Guideline Recommendations on Insulin Therapy in Type 2 Diabetes Mellitus Over the Last Two Decades: A Narrative Review
    Manoj D. Chadha, Sunil M. Jain, Rajeev Chawla, Mala Dharmalingam, Tirthankar Chaudhury, Pradeep Talwalkar, Sudhir Tripathi, S Singh, Manish Gutch, Arundhati Dasgupta · 2023 · Current Diabetes Reviews
  26. Critical appraisal and systematic review of guidelines for perioperative diabetes management: 2011–2017
    Xiaoyang Song, Jinjing Wang, Yuting Gao, Yang Yu, Jingyi Zhang, Qi Wang, Xiaoting Ma, Janne Estille, Xinye Jin, Yaolong Chen et al. · 2018 · Endocrine
  27. Assessment of a screening protocol for type 2 diabetes in community pharmacy. The DiabNow Study
    Narjis Fikri‐Benbrahim, Fernando Martínez‐Martínez, Loreto Sáez‐Benito, Blanca Suárez Luque, José Pedro García Corpas, Joanna C. Moullin, Daniel Sabater‐Hernández · 2015 · Diabetes Research and Clinical Practice
  28. The Design and Development of a Computer Game on Insulin Injection
    F. Ebrahimpour, M. Najafi, N. Sadeghi · 2014 · Electronic Physician
  29. Glycemic Targets and Medication Limitations for Type 2 Diabetes Mellitus in the Older Adult
    Angela M. Thompson, Sunny Anne Linnebur, Joseph P. Vande Griend, Joseph J. Saseen · 2014 · The Consultant Pharmacist
  30. Treat-to-target comparison between once daily biphasic insulin aspart 30 and insulin glargine in Chinese and Japanese insulin-naïve subjects with type 2 diabetes
    Wenying Yang, Xiangjin Xu, Xiao-Min Liu, Gangyi Yang, Yutaka Seino, Henning Andersen, Hideaki Jinnouchi · 2013 · Current Medical Research and Opinion
  31. Colesevelam Plus Rosuvastatin 5 mg/Day Versus Rosuvastatin 10 mg/Day Alone on Markers of Insulin Resistance in Patients with Hypercholesterolemia and Impaired Fasting Glucose
    Matilda Florentin, Evangelos N. Liberopoulos, Christos V. Rizos, Anastazia A. Kei, George L. Liamis, Michael S. Kostapanos, Moses Elisaf · 2012 · Metabolic Syndrome and Related Disorders
  32. Physiologic and Weight-Focused Treatment Strategies for Managing Type 2 Diabetes Mellitus: The Metformin, Glucagon-Like Peptide-1 Receptor Agonist, and Insulin (MGI) Approach
    Daniel A. Nadeau · 2013 · Postgraduate Medicine
  33. Significance of Haemodynamic and Haemostatic Factors in the Course of Different Manifestations of Cerebral Small Vessel Disease: The SHEF-CSVD Study—Study Rationale and Protocol
    Jacek Staszewski, Renata Piusińska‐Macoch, Ewa Skrobowska, Bogdan Brodacki, Rafał Pawlik, Tomasz Dutkiewicz, Wiesław Piechota, Alicja Rączka, Kazimierz Tomczykiewicz, Adam Stępień · 2013 · Neuroscience Journal
  34. Thr92Ala Polymorphism of Human Type 2 Deiodinase Gene (hD2) Affects the Development of Graves' Disease, Treatment Efficiency, and Rate of Remission
    Babenko Alina, Popkova Daria, F. Olga, S. Vladislav, Kostareva Anna, G. Elena · 2012 · Clinical and Developmental Immunology
  35. Effectiveness of certified diabetes educators following pre-approved protocols to redesign diabetes care delivery in primary care: Results of the REMEDIES 4D trial
    Janice C. Zgibor, Maura A. Maloney, Markku Malmi, Anthony Fabio, Shihchen Kuo, Francis X. Solano, Debra Tilves, Lichuan Tu, Mayer B. Davidson · 2017 · Contemporary Clinical Trials
  36. Self-monitoring of blood glucose among diabetic patients attending Al-Eskan Primary Health Care Center in Makkah Al-Mukarramah city -
    Deyaa Mansouri, H. Alawi, Khairyah Bakur Barasyn, Morouj Nizar Bnnounh, N. Haddad, Dalia Awad Al-Hafdey, Ebtehal Khayat · 2015
  37. Trends in the Use of Eye Care Services in Adults Treated for Diabetes between 2008 and 2017 in France: A Nationwide Study
    A. Cougnard-Grégoire, J. Korobelnik, M. Delyfer, V. Rigalleau, V. Daien, C. Creuzot-Garcher, C. Delcourt · 2020 · Ophthalmic Research
  38. The Effectiveness of Okra Fruit (Abelmoschus Esculentus) on Fasting Blood Sugar and Total Cholesterol Level in Type 2 Diabetes Mellitus
    Haryati, Mubarak, Rahmawati · 2019 · Annals of Tropical Medicine and Public Health
  39. Is risk stratification ever the same as ‘profiling’?
    Ronald Scott Braithwaite, Elizabeth R. Stevens, Arthur L. Caplan · 2016 · Journal of Medical Ethics
  40. Linagliptin for the treatment of type 2 diabetes mellitus: a drug safety evaluation
    A. Barnett · 2015 · Expert Opinion on Drug Safety
  41. Transcultural Diabetes Nutrition Algorithm: The Mexican Application
    Alexis Bolio Galvis · 2014 · Journal of Diabetes & Metabolism
  42. ADAG Study Group Data Links A1C Levels with Empirically Measured Blood Glucose Values - New Treatment Guidelines Will Now be Needed
    David Charles Klonoff · 2014 · Journal of Diabetes Science and Technology
  43. Clinical Considerations for Insulin Pharmacotherapy in Ambulatory Care, Part One: Introduction and Review of Current Products and Guidelines
    John A. Galdo, Maria Miller Thurston, Catherine A. Bourg · 2014 · Clinical Diabetes
  44. The Dipeptidyl Peptidase (DPP)-4 Inhibitors for Type 2 Diabetes Mellitus in Challenging Patient Groups
    David S. Kountz · 2013 · Advances in Therapy
  45. Psychosocial management of diabetes in pregnancy
    B. Kalra, G. Sridhar, K. Madhu, Y. Balhara, R. Sahay, S. Kalra · 2013 · Indian journal of endocrinology and metabolism
  46. Initial Combination with Linagliptin and Metformin in Newly Diagnosed Type 2 Diabetes and Severe Hyperglycemia
    Thomas Haak · 2012 · Advances in Therapy
  47. Managing dyslipidemia for CVD prevention
    Nicole A. Ciffone, TINA M. COPPLE · 2018 · The Nurse Practitioner
  48. The Challenges of Iran's Type 2 Diabetes Prevention and Control Program
    R. Valizadeh, L. Vali, K. Bahaadinbeigy, M. Amiresmaili · 2019 · International Journal of Preventive Medicine
  49. The postpartum effect of maternal diabetes on the circulating levels of sirtuins and superoxide dismutase
    Samar Sultan, Nada Alzahrani, Kalthoom Al‐Sakkaf · 2017 · FEBS Open Bio
  50. The profile of hypertension and dyslipidemia in prediabetic subjects; results of the Isfahan Diabetes Prevention program: A large population-based study
    Ramin Salami, Bijan Iraj, Awat Feizi, Massoud Amini · 2015 · Advanced Biomedical Research
  51. The Role of Bariatric Surgery in the Treatment of Type 2 Diabetes: Current Evidence and Clinical Guidelines
    Michael A. Via, J. Mechanick · 2013 · Current Atherosclerosis Reports
  52. Evidence-based clinical use of insulin premixtures
    M. Tambascia, M. Nery, J. Gross, M. N. Ermetice, C. P. de Oliveira · 2013 · Diabetology & Metabolic Syndrome
  53. Use of the dipeptidyl peptidase-4 inhibitor linagliptin in combination therapy for type 2 diabetes
    Rosemarie Lajara · 2012 · Expert Opinion on Pharmacotherapy
  54. Insulin Tactics in Type 2 Diabetes
    Farah A. Meah, Rattan Juneja · 2014 · Medical Clinics of North America
  55. Analysis of global DNA methylation and epigenetic modifiers (DNMTs and HDACs) in human foetal endothelium exposed to gestational and type 2 diabetes
    Samar Sultan, Sultanh AlMalki · 2023 · Epigenetics
  56. A review of the clinical utility of duloxetine in the treatment of diabetic peripheral neuropathic pain
    J. King, Marisa B. Schauerhamer, B. Bellows · 2015 · Therapeutics and Clinical Risk Management
  57. Rationale and design of the multinational observational study assessing insulin use: the MOSAIc study
    Jennifer M. Polinski, Bradley H. Curtis, J. Seeger, N. Choudhry, A. Zagar, W. Shrank · 2012 · BMC Endocrine Disorders
  58. Effectiveness of Primary Care–Relevant Treatments for Obesity in Adults
    L. Kuller · 2012 · Annals of Internal Medicine
  59. Assessing Cardiovascular Risk Factors and Selecting Agents to Successfully Treat Patients With Type 2 Diabetes Mellitus
    Mark D. Baldwin · 2011 · The Journal of the American Osteopathic Association
  60. Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach
    A. Das, B. Saboo, R. Chawla, S. Aravind, R. Rajput, A. Singh, J. Mukherjee, A. Jhingan, P. Shah, V. Deshmukh et al. · 2023 · International Journal of Diabetes in Developing Countries
  61. Impact of a Clinical Pharmacist Intervention Program on the Follow-up of Type-2 Diabetic Patients
    Abdel-Hameed I. Mohammed Ebid, M. A. Mobarez, R. Ramadan, M. Mahmoud · 2020 · Hospital Pharmacy
  62. Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets (IMPACT) trial
    Eugenia Gianos, Antoinette Schoenthaler, Yu Guo, Judy Zhong, HOWARD S. WEINTRAUB, Arthur Z. Schwartzbard, James A. Underberg, Michael G. Schloss, Jonathan D. Newman, Sean P. Heffron et al. · 2018 · American Heart Journal
  63. Simultaneous control of blood glucose, blood pressure, and lipid among drug-treated Type 2 diabetes patients from Shaanxi province, North-Western China: A multicenter study.
    S. Xu, F. Sun, W. Xu, K. Jiao, Bingyin Shi, X. Xie, Y. Wang, M. Zhu, Q. Ji · 2016 · Nigerian Journal of Clinical Practice
  64. Determining starting basal rates of insulin infusion for insulin pump users: a comparison between methods
    Nelson Chow, Daniel Shearer, Hamish G. Tildesley, Jessica Aydin Plaa, Betty Pottinger, Monika Pawlowska, Adam S. White, Ann Priestman, S. Ross, H. Tildesley · 2016 · BMJ Open Diabetes Research & Care
  65. Implications of incretin-based therapies on cardiovascular disease
    Melissa E. Rotz, Valerie S. Ganetsky, S. Sen, Tyan F. Thomas · 2014 · International Journal of Clinical Practice
  66. Critical Appraisal of International Guidelines for the Management of Diabetic Neuropathy: Is There Global Agreement in the Internet Era?
    Mingfang Sun, Min Zhang, Jing Shen, Juping Yan, Bo Zhou · 2015 · International Journal of Endocrinology
  67. Self-reported frequency and impact of non-severe hypoglycemic events in insulin-treated diabetic patients in Denmark
    Marie Markert Jensen, Ulrik Pedersen‐Bjergaard · 2014 · Diabetes Management
  68. AACE/ACE Disease State Clinical Review: Dopamine Agonists for Hyperprolactinemia and the Risk of Cardiac Valve Disease.
    S. Samson, S. Ezzat · 2014 · Endocrine Practice
  69. Reshaping Diabetes Care: The Fundamental Role of Dipeptidyl Peptidase-4 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Clinical Practice
    Guillermo E. Umpierrez, Luigi Meneghini · 2013 · Endocrine Practice
  70. Tolerability and efficacy of glycemic control with saxagliptin in older patients (aged ≥ 65 years) with inadequately controlled type 2 diabetes mellitus
    Chetan S. Karyekar, Shoba Ravichandran, E. Allen, Douglas Fleming, R. Frederich · 2013 · Clinical Interventions in Aging
  71. The Role of the Kidney in Hyperglycemia
    Debbie Hinnen · 2013 · The Journal of Cardiovascular Nursing
  72. Overview of the Guidelines and Evidence for the Pharmacologic Management of Type 2 Diabetes Mellitus
    Cara Liday · 2011 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  73. Hypoglycemia in Type 2 Diabetes—Consequences and Risk Assessment
    Ildiko Lingvay · 2011 · US Endocrinology
  74. Electronic Health Record Summarization over Heterogeneous and Irregularly Sampled Clinical Data
    Rimma Pivovarov · 2015
  75. Inhibition of renal glucose reabsorption as a novel treatment for diabetes patients.
    E. Cersosimo, Carolina Solis-Herrera, C. Triplitt · 2014 · Jornal Brasileiro De Nefrologia
  76. Screening for depression in diabetic Patients
    Mohammad Zaki al-Baik, Maha Moharram, T. Elsaid, S. Albaik, Salah M Aldahan, N. Alkhadhrawi, Y. Al-Omran, Amenah Dahneam · 2014 · International Journal of Medical Science and Public Health
  77. Predictors of Glycaemic Control among Ghanaian Type 2 Diabetic Patients Using Diabetes Self-management Approach
    R. Apini, R. Annan, C. Apprey, Odeafo Asamoah-Boakye · 2018 · International Journal of Biochemistry Research & Review
  78. Sodium Glucose Transporter 2 Inhibitors and Diabetic Ketoacidosis in Three Patients with Diabetes: Underlying Causation
    J. Kelley, M. Strum, D. Riche, A. Chandler · 2017 · Journal of Pharmacology and Pharmacotherapeutics
  79. Trends in the Care and Outcomes of Medicare Beneficiaries with Type 2 Diabetes, 2002–2011
    Kristen A. Hyland, Melissa A. Greiner, Laura Goettinger Qualls, Robert M. Califf, Adrian F. Hernandez, Lesley H. Curtis · 2016 · Endocrine Practice
  80. Glycemic Control and Hospital Admission Risk in Type 1 Diabetes is Related to the Use of Carbohydrate Counting and Frequency of Self- Monitoring of Blood Glucose: RSD1 Study
    Fern, O. Gomez-Peralta, A. López-Guzmán, M. Delgado, Rocío Villar-Taibo, C. Abreu, Estefanía Santos, Luis R. Santiago, Victor Puigdeva · 2015
  81. Pharmacologic Management of Types 1 and 2 Diabetes Mellitus and Their Complications in Women of Childbearing Age
    Mimi S. Mukherjee, Valerie Azzopardi Coppenrath, Bree A. Dallinga · 2015 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  82. A Concept Analysis of Individualized Aging
    Daniel D. Cline · 2014 · Nursing Education Perspectives
  83. Treating Patients With Diabetes of Long Duration: GLP-1 Receptor Agonists and Insulin in Combination
    E. Moghissi · 2014 · The Journal of the American Osteopathic Association
  84. Insulin use in long term care settings for patients with type 2 diabetes mellitus: a systematic review of the literature.
    K. Van Brunt, Bradley H. Curtis, K. Brooks, A. Heinloth, Rita de Cassia Castro · 2013 · Journal of the American Medical Directors Association
  85. The role of primary pharmacological therapy in acromegaly
    A. L. Espinosa de los Monteros, C. Carrasco, Alfredo Reza Albarrán, M. Gadelha, Alin Abreu, M. Mercado · 2013 · Pituitary
  86. Guidelines for ethno-centric psychosocial management of diabetes mellitus in India: The north east consensus group statement
    S. Kalra, M. Baruah, S. Ranabir, Ngb Singh, A. B. Choudhury, S. Sutradhar, S. Adhikari, Ananda Dehingia, Dambaru Dhar Mili, Kevito Hesso et al. · 2013 · Journal of social health and diabetes
  87. Insulin therapy for type 2 diabetes
    Luigi Meneghini · 2012 · Endocrine
  88. Current Issues in Glp-1 Receptor Agonist Therapy for Type 2 Diabetes
    Zachary T. Bloomgarden, Lawrence Blonde, Alan J. Garber, Carol Wysham · 2012 · Endocrine Practice
  89. The Effects of Lifestyle Modification on Glycemic Levels and Medication Intake: The Rockford CHIP
    H. Englert, H. Dieh, R. Greenlaw, S. Aldana · 2012 · InTech eBooks
  90. A Review and Critical Analysis of Professional Societies’ Guidelines for Pharmacologic Management of Type 2 Diabetes Mellitus
    R. Vigersky · 2012 · Current Diabetes Reports
  91. A nomogram model for predicting malnutrition among older hospitalized patients with type 2 diabetes: a cross—sectional study in China
    Qian Ran, Xi-Li Zhao, Jiao Tian, Siyuan Gong, Xia Zhang · 2023 · BMC Geriatrics
  92. Is calcitonin gene-related peptide a modulator of menopausal vasomotor symptoms?
    Maria Alice de Oliveira, William Gustavo Lima, Dante Alighieri Schettini, Cristiane Queixa Tilelli, Valéria Ernestânia Chaves · 2018 · Endocrine
  93. Measuring adherence rate to quality indicators for diabetes care identified by primary health care in Bahrain.
    Basem A. Alubaidi, Mohammed A Al-Khadraji, B. Al-Hermi · 2014 · Saudi Medical Journal
  94. Efficacy and safety of initial combination of DPP‐IV inhibitors and metformin versus metformin monotherapy in type 2 diabetes: a systematic review of randomized controlled trials
    Weiyi Gao, Jianjun Dong, J. Liu, Y. Li, Fupeng Liu, Long-Shan Yang, Xinli Zhou, Lin Liao · 2013 · Diabetes Obesity and Metabolism
  95. Glucose and Low-Density Lipoprotein Cholesterol Lowering in Elderly Patients with Type 2 Diabetes
    J. Marrs · 2012 · Drugs & Aging
  96. Octreotide long-acting repeatable for acromegaly
    Renato Cesare Cozzi, Roberto Attanasio · 2012 · Expert Review of Clinical Pharmacology
  97. Effectiveness of primary care-relevant treatments for obesity in adults.
    A. Moses, Y. Handelsman, D. Einhorn · 2012 · Annals of Internal Medicine
  98. Managing Special Populations Among Patients with Type 2 Diabetes Mellitus
    Jonathan G. Marquess · 2011 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  99. POP-PL: a patient-oriented prescription programming language
    Spencer P. Florence, B. Fetscher, M. Flatt, W. Temps, T. Kiguradze, D. West, Charlotte M. Niznik, P. Yarnold, R. Findler, S. Belknap · 2015 · International Conference on Generative Programming: Concepts and Experiences
  100. Rationale and design of the Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets (IMPACT) trial
    Eugenia Gianos, Antoinette Schoenthaler, Michael Mushailov, Edward A A Fisher, Jeffrey S. Berger · 2015 · American Heart Journal